Richter and Allergan Announce FDA has Extended the Review Period for Cariprazine to September 2015
6/16/2015
Business related Regulatory Marketing authorization application postponed Central Nervous System PARTNER - ALLERGAN / ABBVIE / ACTAVIS API - CARIPRAZINE